{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:10Z","timestamp":1791357490547,"version":"4.3.1"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.schres.2022.11.015","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T01:41:06Z","timestamp":1668735666000},"page":"265-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Treatment of schizophrenia with catatonic symptoms: A narrative review"],"prefix":"10.1016","volume":"263","author":[{"given":"Stanley N.","family":"Caroff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor S.","family":"Ungvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Gazdag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2022.11.015_bb0005","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/archpsyc.1976.01770050043006","article-title":"Catatonia. A prospective clinical study","volume":"33","author":"Abrams","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0010","first-page":"1","article-title":"The course of schizophrenia and schizophreniform psychoses","volume":"155","author":"Achte","year":"1961","journal-title":"Acta Psychiatr. Neurol. Scand. Suppl."},{"key":"10.1016\/j.schres.2022.11.015_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.schres.2022.11.015_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2022"},{"key":"10.1016\/j.schres.2022.11.015_bb0025","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","article-title":"Neuroleptic malignant syndrome and atypical antipsychotic drugs","volume":"65","author":"Ananth","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0030","series-title":"The Scale for the Assessment of Negative Symptoms (SANS)","author":"Andreasen","year":"1983"},{"key":"10.1016\/j.schres.2022.11.015_bb0035","series-title":"Scale for the Assessment of Positive Symptoms","author":"Andreasen","year":"1984"},{"key":"10.1016\/j.schres.2022.11.015_bb0040","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1982.04290070025006","article-title":"Negative v positive schizophrenia. Definition and validation","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0045","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1097\/MJT.0000000000000311","article-title":"Amisulpride augmentation in acute catatonia","volume":"24","author":"Arora","year":"2017","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.schres.2022.11.015_bb0050","first-page":"133","article-title":"The response of the different Leonhard subgroups of schizophrenia of psychotropic drugs","volume":"18","author":"Astrup","year":"1964","journal-title":"Folia Psychiatr. Neurol. Jpn."},{"key":"10.1016\/j.schres.2022.11.015_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000284677","article-title":"Clinical pharmacology and Leonhard's classification of endogenous psychoses","volume":"23","author":"Ban","year":"1990","journal-title":"Psychopathology"},{"issue":"1","key":"10.1016\/j.schres.2022.11.015_bb0060","first-page":"439","article-title":"Experimental catatonia induced by chlorpromazine","volume":"113","author":"Baruk","year":"1955","journal-title":"Ann. Med. Psychol. (Paris)"},{"key":"10.1016\/j.schres.2022.11.015_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2017.06.011","article-title":"Alternative treatment strategies for catatonia: a systematic review","volume":"48","author":"Beach","year":"2017","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000118896","article-title":"The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics","volume":"26","author":"Beckmann","year":"1992","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2022.11.015_bb0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/WNF.0000000000000462","article-title":"Clozapine withdrawal-induced malignant catatonia or neuroleptic malignant syndrome: a case report and a brief review of the literature","volume":"44","author":"Belteczki","year":"2021","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.schres.2022.11.015_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hup.376","article-title":"Clinical risk factors for neuroleptic malignant syndrome","volume":"17","author":"Berardi","year":"2002","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2022.11.015_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.schres.2017.09.008","article-title":"Historical and conceptual aspects of motor disorders in the psychoses","volume":"200","author":"Berrios","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0090","first-page":"745","article-title":"An unusual complication following the use of trilafon in children","volume":"9","author":"Berry","year":"1958","journal-title":"U. S. Armed Forces Med. J."},{"key":"10.1016\/j.schres.2022.11.015_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0010-440X(97)90027-4","article-title":"Catatonia and the neuroleptics: psychobiologic significance of remote and recent findings","volume":"38","author":"Blumer","year":"1997","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.yct.0000165500.60784.05","article-title":"The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia","volume":"21","author":"Braga","year":"2005","journal-title":"J. ECT"},{"key":"10.1016\/j.schres.2022.11.015_bb0105","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1176\/ajp.135.10.1242","article-title":"The catatonic dilemma","volume":"135","author":"Brenner","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia. I. Rating scale and standardized examination","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.11.015_bb0115","first-page":"79","article-title":"The neuroleptic malignant syndrome","volume":"41","author":"Caroff","year":"1980","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0120","first-page":"25","article-title":"Neuroleptic malignant syndrome","volume":"24","author":"Caroff","year":"1988","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2022.11.015_bb0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med. Clin. North Am."},{"issue":"Suppl. 4","key":"10.1016\/j.schres.2022.11.015_bb0130","first-page":"12","article-title":"Movement disorders associated with atypical antipsychotic drugs","volume":"63","author":"Caroff","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0135","series-title":"Catatonia; From Psychopathology to Neurobiology","first-page":"15","article-title":"Epidemiology","author":"Caroff","year":"2004"},{"key":"10.1016\/j.schres.2022.11.015_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4088\/JCP.09m05793yel","article-title":"Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia","volume":"72","author":"Caroff","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.9758\/cpn.2015.13.2.218","article-title":"Recurrent idiopathic catatonia: implications beyond the Diagnostic and Statistical Manual of Mental Disorders 5th Edition","volume":"13","author":"Caroff","year":"2015","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.schres.2022.11.015_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9758\/cpn.2021.19.1.1","article-title":"Drug-induced hyperthermic syndromes in psychiatry","volume":"19","author":"Caroff","year":"2021","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.schres.2022.11.015_bb0155","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/ajp.145.5.578","article-title":"Deficit and nondeficit forms of schizophrenia: the concept","volume":"145","author":"Carpenter","year":"1988","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0160","first-page":"50","article-title":"Efficacy and tolerance of risperidone in various doses (report of a study)","volume":"92","author":"Ceskov\u00e1","year":"1996","journal-title":"Ceska Slov. Psychiatr."},{"key":"10.1016\/j.schres.2022.11.015_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-1781(01)00321-3","article-title":"Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome","volume":"105","author":"Chanpattana","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0972-6748.110955","article-title":"Clozapine responsive catatonia: a series of five cases","volume":"21","author":"Chattopadhyay","year":"2012","journal-title":"Ind. Psychiatry J."},{"key":"10.1016\/j.schres.2022.11.015_bb0175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000065140","article-title":"Chinese classification of mental disorders (CCMD-3): towards integration in international classification","volume":"35","author":"Chen","year":"2002","journal-title":"Psychopathology"},{"key":"10.1016\/j.schres.2022.11.015_bb0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.psychres.2014.12.048","article-title":"Abnormal movements in first-episode, nonaffective psychosis: dyskinesias, stereotypies, and catatonic-like signs","volume":"226","author":"Compton","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0185","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/schbul\/11.3.471","article-title":"The two-syndrome concept: origins and current status","volume":"11","author":"Crow","year":"1985","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.11.015_bb0190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1192\/bjp.bp.108.055137","article-title":"Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis","volume":"194","author":"Cuesta","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.886662","article-title":"Catatonia psychopathology and phenomenology in a large dataset","volume":"13","author":"Dawkins","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0200","first-page":"145","article-title":"Un neuroleptique majeur non-phenothiazine et non-reserpinique, l'haloperidol, dans le traitement des psychoses","volume":"118","author":"Delay","year":"1960","journal-title":"Ann. Med.Psychol."},{"key":"10.1016\/j.schres.2022.11.015_bb0205","series-title":"5th World Congress of Psychiatry","first-page":"262","article-title":"Treatment of chronic psychotic patients with high doses of propericiazine","author":"Denef","year":"1971"},{"key":"10.1016\/j.schres.2022.11.015_bb0210","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1177\/0269881105053313","article-title":"Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?","volume":"19","author":"Dursun","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2022.11.015_bb0215","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.23.2.jnp223","article-title":"Catatonia in psychotic patients: clinical features and treatment response","volume":"23","author":"England","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.schres.2022.11.015_bb0220","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3999(00)00190-2","article-title":"Clinical and cerebral blood flow changes in catatonic patients treated with ECT","volume":"49","author":"Escobar","year":"2000","journal-title":"J. Psychosom. Res."},{"issue":"Suppl. 4","key":"10.1016\/j.schres.2022.11.015_bb0225","first-page":"10","article-title":"Prevalence of spontaneous dyskinesia in schizophrenia","volume":"61","author":"Fenton","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0230","first-page":"1","article-title":"Is catatonia a primary indication for ECT?","volume":"6","author":"Fink","year":"1990","journal-title":"Convuls. Ther."},{"key":"10.1016\/j.schres.2022.11.015_bb0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1034\/j.1399-5618.1999.10112.x","article-title":"Delirious mania","volume":"1","author":"Fink","year":"1999","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.schres.2022.11.015_bb0240","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s007020170041","article-title":"Catatonia: syndrome or schizophrenia subtype? Recognition and treatment","volume":"108","author":"Fink","year":"2001","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.schres.2022.11.015_bb0245","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/acps.12796","article-title":"Does persisting fear sustain catatonia?","volume":"136","author":"Fink","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.11.015_bb0250","series-title":"Catatonia: A Clinician's Guide to Diagnosis and Treatment","author":"Fink","year":"2003"},{"key":"10.1016\/j.schres.2022.11.015_bb0255","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbp059","article-title":"Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature","volume":"36","author":"Fink","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"SUPPL","key":"10.1016\/j.schres.2022.11.015_bb0260","first-page":"245","article-title":"The influence of the tranquilizers on the Leonhard schizophrenic syndromes","volume":"53","author":"Fish","year":"1964","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.schres.2022.11.015_bb0265","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.euroneuro.2021.11.008","article-title":"The polysemous concepts of psychomotricity and catatonia: a european multi-consensus perspective","volume":"56","author":"Foucher","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2022.11.015_bb0270","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/YCT.0b013e3181fe28bd","article-title":"Catatonia in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition","volume":"26","author":"Francis","year":"2010","journal-title":"J ECT"},{"key":"10.1016\/j.schres.2022.11.015_bb0275","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.biopsych.2022.05.009","article-title":"Prefrontal and striatal dopamine release are inversely correlated in schizophrenia","volume":"92","author":"Frankle","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0280","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0006-3223(85)90060-5","article-title":"Neuroleptic catatonia and its relationship to psychogenic catatonia","volume":"20","author":"Fricchione","year":"1985","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0285","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-444-64196-0.00012-1","article-title":"Cingulate-basal ganglia-thalamo-cortical aspects of catatonia and implications for treatment","volume":"166","author":"Fricchione","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.schres.2022.11.015_bb0290","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00004714-198312000-00002","article-title":"Intravenous lorazepam in neuroleptic-induced catatonia","volume":"3","author":"Fricchione","year":"1983","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2022.11.015_bb0295","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/088506669701200304","article-title":"Recognition and treatment of the catatonic syndrome","volume":"12","author":"Fricchione","year":"1997","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.schres.2022.11.015_bb0300","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3928\/0048-5713-20000501-12","article-title":"Catatonia, lethal catatonia and neuroleptic malignant syndrome","volume":"30","author":"Fricchione","year":"2000","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.schres.2022.11.015_bb0305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0893-133X(88)90014-0","article-title":"Dopamine as a mediator of a central stabilizing system","volume":"1","author":"Friedhoff","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2022.11.015_bb0310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0893-133X(95)00047-H","article-title":"Repeated inescapable stress produces a neuroleptic-like effect on the conditioned avoidance response","volume":"13","author":"Friedhoff","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2022.11.015_bb0315","series-title":"Psychopathology: Experimental Models","article-title":"Tonic immobility: evolutionary underpinnings of human catalepsy and catatonia","author":"Gallup","year":"1977"},{"key":"10.1016\/j.schres.2022.11.015_bb0320","first-page":"261","article-title":"The augmentation of clozapine treatment with electroconvulsive therapy","volume":"59","author":"Gazdag","year":"2006","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.schres.2022.11.015_bb0325","series-title":"Electroconvulsive and Neuromodulation Therapies","first-page":"124","article-title":"Clinical evidence for the efficacy of electroconvulsive therapy in the treatment of catatonia and psychoses","author":"Gazdag","year":"2009"},{"key":"10.1016\/j.schres.2022.11.015_bb0330","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(76)92669-6","article-title":"The catatonic syndrome","volume":"1","author":"Gelenberg","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2022.11.015_bb0335","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archpsyc.1977.01770200085010","article-title":"Catatonic reactions to high-potency neuroleptic drugs","volume":"34","author":"Gelenberg","year":"1977","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2022.11.015_bb0340","article-title":"Benzodiazepines for catatonia in people with schizophrenia and other serious mental illnesses","author":"Gibson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.schres.2022.11.015_bb0345","first-page":"21","article-title":"Electroconvulsive therapy in lorazepam non-responsive catatonia","volume":"45","author":"Girish","year":"2003","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0350","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005053-197404000-00007","article-title":"Catatonic schizophrenia: epidemiology and clinical course. A 7-year register study of 798 cases","volume":"158","author":"Guggenheim","year":"1974","journal-title":"J. Nerv. Ment. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2022.11.015_bb0355","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2007-1000734","article-title":"Effectiveness of zotepine in therapy-refractory psychoses. An open, multicenter study in eight psychiatric clinics","volume":"59","author":"Harada","year":"1991","journal-title":"Fortschr. Neurol. Psychiatr."},{"key":"10.1016\/j.schres.2022.11.015_bb0360","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0447.2004.00450.x","article-title":"Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the pan-european schizophrenia outpatient health outcomes (SOHO) study","volume":"111","author":"Haro","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.11.015_bb0365","series-title":"The Chemical Capture of Animals","author":"Harthoorn","year":"1976"},{"key":"10.1016\/j.schres.2022.11.015_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaclp.2022.07.003","article-title":"Electroconvulsive therapy-resistant catatonia: case report and literature review","author":"Hasoglu","year":"2022","journal-title":"J. Acad. Consult. Liaison Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0375","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/yct.0b013e3181587949","article-title":"Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms","volume":"23","author":"Hatta","year":"2007","journal-title":"J. ECT"},{"key":"10.1016\/j.schres.2022.11.015_bb0380","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2190\/X0FF-VU7G-QQP7-L5V7","article-title":"Somatic treatment of catatonia","volume":"25","author":"Hawkins","year":"1995","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.schres.2022.11.015_bb0385","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neubiorev.2018.01.011","article-title":"Motor dysfunction as research domain in the period preceding manifest schizophrenia: a systematic review","volume":"87","author":"Hirjak","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.schres.2022.11.015_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00115-018-0582-5","article-title":"Antipsychotic-induced motor symptoms in schizophrenic psychoses-part 1: dystonia, akathisia und parkinsonism","volume":"90","author":"Hirjak","year":"2019","journal-title":"Nervenarzt"},{"key":"10.1016\/j.schres.2022.11.015_bb0395","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1038\/s41380-021-01158-2","article-title":"Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon","volume":"26","author":"Hirjak","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0400","article-title":"The origins of catatonia - systematic review of historical texts between 1800 and 1900","author":"Hirjak","year":"2022","journal-title":"Schizophr Res"},{"key":"10.1016\/j.schres.2022.11.015_bb0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I","article-title":"The nurses' observation scale for inpatient evaluation: a new scale for measuring improvement in chronic schizophrenia","volume":"21","author":"Honigfeld","year":"1965","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.schres.2022.11.015_bb0410","article-title":"Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms","volume":"7","author":"Huang","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.schres.2022.11.015_bb0415","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.mp.4001857","article-title":"Subtyping schizophrenia: implications for genetic research","volume":"11","author":"Jablensky","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0420","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0425","series-title":"Catatonia: From Psychopathology to Neurobiology","first-page":"189","article-title":"Animal models","author":"Kanes","year":"2004"},{"key":"10.1016\/j.schres.2022.11.015_bb0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5334\/tohm.695","article-title":"Tardive syndromes with novel antipsychotic agents","volume":"12","author":"Kannarkat","year":"2022","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.schres.2022.11.015_bb0435","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.11.015_bb0440","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1080\/00207450902984002","article-title":"Rotarod impairment: catalepsy-like screening test for antipsychotic side effects","volume":"119","author":"Kirschbaum","year":"2009","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.schres.2022.11.015_bb0445","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajp.2011.04.007","article-title":"A comparative study of \"Idiopathic catatonia\" with catatonia in schizophrenia","volume":"4","author":"Krishna","year":"2011","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2022.11.015_bb0450","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0010-440X(03)00108-1","article-title":"Factor analysis of the catatonia rating scale and catatonic symptom distribution across four diagnostic groups","volume":"44","author":"Kr\u00fcger","year":"2003","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0455","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41398-018-0192-9","article-title":"Review of withdrawal catatonia: what does this reveal about clozapine?","volume":"8","author":"Lander","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0460","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-244X-12-65","article-title":"Clinical features of delirious mania: a series of five cases and a brief literature review","volume":"12","author":"Lee","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0465","series-title":"Aufteilung der Endogenen Psychosen","author":"Leonhard","year":"1957"},{"key":"10.1016\/j.schres.2022.11.015_bb0470","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S2215-0366(22)00304-2","article-title":"The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis","volume":"9","author":"Leucht","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0475","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.schres.2022.11.015_bb0480","first-page":"32","article-title":"A comparative study of modified electroconvulsive therapy for catatonic schizophrenia","volume":"21","author":"Liu","year":"2008","journal-title":"Shandong Arch. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0485","series-title":"Catatonia: From Psychopathology to Neurobiology","first-page":"129","article-title":"Drug-induced catatonia","author":"Lopez-Canino","year":"2004"},{"issue":"323-327","key":"10.1016\/j.schres.2022.11.015_bb0490","first-page":"326","article-title":"Motor, volitional and behavioural disorders in schizophrenia. 1: Assessment using the Modified Rogers Scale","volume":"158","author":"Lund","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0495","series-title":"Neuroleptic Malignant Syndrome and Related Conditions","first-page":"121","article-title":"Malignant catatonia","author":"Mann","year":"2003"},{"key":"10.1016\/j.schres.2022.11.015_bb0500","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1176\/ajp.143.11.1374","article-title":"Lethal catatonia","volume":"143","author":"Mann","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0505","first-page":"239","article-title":"Electroconvulsive therapy of the lethal catatonia syndrome","volume":"6","author":"Mann","year":"1990","journal-title":"Convuls. Ther."},{"key":"10.1016\/j.schres.2022.11.015_bb0510","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3928\/0048-5713-20000501-14","article-title":"Central dopamine hypoactivity and the pathogenesis of neuroleptic malignant syndrome","volume":"30","author":"Mann","year":"2000","journal-title":"Psychiatr. Ann."},{"key":"10.1016\/j.schres.2022.11.015_bb0515","series-title":"Catatonia: From Psychopathology to Neurobiology","article-title":"Malignant catatonia","author":"Mann","year":"2004"},{"key":"10.1016\/j.schres.2022.11.015_bb0520","series-title":"Medical Illness and Schizophrenia","first-page":"185","article-title":"Neurological comorbidity and features in schizophrenia","author":"Manschreck","year":"2003"},{"key":"10.1016\/j.schres.2022.11.015_bb0525","series-title":"Psychiatric Aspects of Neurologic Disease","article-title":"Spontaneous and drug-induced movement disorders in psychotic patients","author":"Marsden","year":"1975"},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2022.11.015_bb0530","first-page":"25","article-title":"An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms","volume":"62","author":"Martenyi","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2022.11.015_bb0535","article-title":"Pericyazine for schizophrenia","author":"Matar","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.schres.2022.11.015_bb0540","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/ajp.115.12.1119","article-title":"Catatonic-like states following phenothiazine therapy","volume":"115","author":"May","year":"1959","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0545","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00429281","article-title":"Rigidity, hyperpyrexia and coma following fluphenazine enanthate","volume":"29","author":"Meltzer","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.schres.2022.11.015_bb0550","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/ajp.109.8.617","article-title":"A comparison between unidirectional current nonconvulsive electrical stimulation given with Reiter's machine, standard alternating current electro-shock (Cerletti method), and pentothal in chronic schizophrenia","volume":"109","author":"Miller","year":"1953","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0555","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biopsych.2010.01.021","article-title":"Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period","volume":"68","author":"Mittal","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0560","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fpsyt.2014.00145","article-title":"Beyond boundaries: in search of an integrative view on motor symptoms in schizophrenia","volume":"5","author":"Morrens","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0565","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archpsyc.1973.01750310023005","article-title":"Catatonia. Retarded and excited types","volume":"28","author":"Morrison","year":"1973","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0570","series-title":"Catatonia: From Psychopathology to Neurobiology","first-page":"53","article-title":"Standardized instruments","author":"Mortimer","year":"2004"},{"key":"10.1016\/j.schres.2022.11.015_bb0575","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1037\/0033-295X.111.4.984","article-title":"\"Scared stiff\": catatonia as an evolutionary-based fear response","volume":"111","author":"Moskowitz","year":"2004","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.schres.2022.11.015_bb0580","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1192\/S0007125000296931","article-title":"Clinical management of clozapine patients in relation to efficacy and side-effects","author":"Naber","year":"1992","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.schres.2022.11.015_bb0585","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.genhosppsych.2012.01.011","article-title":"Clinical predictors of response to treatment in catatonia","volume":"34","author":"Narayanaswamy","year":"2012","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.schres.2022.11.015_bb0590","first-page":"34","article-title":"Neurologic comorbidities in schizophrenia","volume":"66","author":"Nasrallah","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0595","article-title":"Describing the features of catatonia: a comparative phenotypic analysis","author":"Oldham","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0600","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1192\/bjp.165.4.548","article-title":"Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis","volume":"165","author":"Osman","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0605","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.schres.2022.11.015_bb0610","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/archpsyc.1982.04290040052008","article-title":"Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics","volume":"39","author":"Owens","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0615","first-page":"57","article-title":"Clozapine in the treatment of schizophrenic patients: an international multicenter trial","volume":"10","author":"Panteleeva","year":"1987","journal-title":"Clin. Ther."},{"key":"10.1016\/j.schres.2022.11.015_bb0620","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1017\/S0033291708004716","article-title":"Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review","volume":"39","author":"Pappa","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2022.11.015_bb0625","first-page":"163","article-title":"Catatonia in a university inpatient service (1985\u20131990)","volume":"8","author":"Pataki","year":"1992","journal-title":"Convuls. Ther."},{"key":"10.1016\/j.schres.2022.11.015_bb0630","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0920-9964(99)00047-X","article-title":"Negative parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited","volume":"40","author":"Peralta","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0635","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-9964(00)00035-9","article-title":"Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia","volume":"47","author":"Peralta","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0640","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/schbul\/sbx089","article-title":"Motor abnormalities: from neurodevelopmental to neurodegenerative through \u201cFunctional\u201d (Neuro)Psychiatric disorders","volume":"43","author":"Peralta","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.11.015_bb0645","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.schres.2009.12.023","article-title":"DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication","volume":"118","author":"Peralta","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0650","article-title":"Neuromotor dysfunction as a major outcome domain of psychotic disorders: a 21-year follow-up study","author":"Peralta","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0655","series-title":"Catatonia: From Psychopathology to Neurobiology","first-page":"151","article-title":"Convulsive therapy","author":"Petrides","year":"2004"},{"key":"10.1016\/j.schres.2022.11.015_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/jnp.6.1.1","article-title":"Malignant catatonia","volume":"6","author":"Philbrick","year":"1994","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2022.11.015_bb0665","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0019-5545.82544","article-title":"Why do we prescribe ECT to schizophrenia patients?","volume":"53","author":"Phutane","year":"2011","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0670","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neubiorev.2021.11.027","article-title":"A systematic review of the prognostic value of motor abnormalities on clinical outcome in psychosis","volume":"132","author":"Pieters","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2022.11.015_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2013.02.005","article-title":"Indications for electroconvulsive treatment in schizophrenia: a systematic review","volume":"146","author":"Pompili","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0680","series-title":"Drug Induced Movement Disorders","first-page":"30","article-title":"Spontaneous movement disorders in psychiatric patients","author":"Richard","year":"2005"},{"key":"10.1016\/j.schres.2022.11.015_bb0685","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1192\/bjp.147.3.221","article-title":"The motor disorders of severe psychiatric illness: a conflict of paradigms","volume":"147","author":"Rogers","year":"1985","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0690","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0165-0327(93)90015-C","article-title":"ECT in the treatment of the catatonic syndrome","volume":"29","author":"Rohland","year":"1993","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2022.11.015_bb0695","series-title":"Catatonia: From Psychopathology to Neurobiology","first-page":"141","article-title":"Pharmacotherapy","author":"Rosebush","year":"2004"},{"key":"10.1016\/j.schres.2022.11.015_bb0700","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/schbul\/sbp141","article-title":"Catatonia and its treatment","volume":"36","author":"Rosebush","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.11.015_bb0705","first-page":"121","article-title":"Severe medical and neurologic complications associated with near-lethal catatonia treated with electroconvulsive therapy","volume":"7","author":"Rummans","year":"1991","journal-title":"Convuls. Ther."},{"key":"10.1016\/j.schres.2022.11.015_bb0710","article-title":"Clozapine as a treatment for catatonia: a systematic review","author":"Saini","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0715","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0920-9964(02)00155-X","article-title":"Negative symptoms and neuroleptics in catatonic schizophrenia","volume":"59","author":"Salokangas","year":"2002","journal-title":"Schizophr. Res."},{"issue":"18","key":"10.1016\/j.schres.2022.11.015_bb0720","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1002\/hbm.25671","article-title":"Intrinsic neural network dynamics in catatonia","volume":"42","author":"Sambataro","year":"2021","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.schres.2022.11.015_bb0725","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/284472a0","article-title":"Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors","volume":"284","author":"Sanberg","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.schres.2022.11.015_bb0730","article-title":"Electroconvulsive therapy for treatment-resistant schizophrenia","volume":"3","author":"Sinclair","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.schres.2022.11.015_bb0735","series-title":"Catatonia; From Psychopathology to Neurobiology","first-page":"173","article-title":"Genetics","author":"St\u00f6ber","year":"2004"},{"key":"10.1016\/j.schres.2022.11.015_bb0740","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2022.11.015_bb0745","first-page":"S54","article-title":"Severe and uncommon involuntary movement disorders due to psychotropic drugs","volume":"37","author":"Stubner","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0750","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00124509-200306000-00003","article-title":"Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia","volume":"19","author":"Suzuki","year":"2003","journal-title":"J. ECT"},{"key":"10.1016\/j.schres.2022.11.015_bb0755","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1503\/jpn.150352","article-title":"Clozapine for the management of persistent catatonia","volume":"41","author":"Tabbane","year":"2016","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.schres.2022.11.015_bb0760","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.schres.2013.04.034","article-title":"Catatonia in DSM-5","volume":"150","author":"Tandon","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0765","first-page":"48","article-title":"Catatonia: a review of a behavioral neurologic syndrome","volume":"3","author":"Taylor","year":"1990","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"10.1016\/j.schres.2022.11.015_bb0770","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archpsyc.1977.01770220105012","article-title":"Catatonia. Prevalence and importance in the manic phase of manic-depressive illness","volume":"34","author":"Taylor","year":"1977","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0775","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1176\/appi.ajp.160.7.1233","article-title":"Catatonia in psychiatric classification: a home of its own","volume":"160","author":"Taylor","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0780","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2018"},{"key":"10.1016\/j.schres.2022.11.015_bb0785","first-page":"463","article-title":"Amineptine treatment of persistent catatonic symptoms in schizophrenia: a controlled study","volume":"12","author":"Ungvari","year":"2010","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.schres.2022.11.015_bb0790","series-title":"Catatonia: From Psychopathology to Neurobiology","first-page":"33","article-title":"Nosology","author":"Ungvari","year":"2004"},{"key":"10.1016\/j.schres.2022.11.015_bb0795","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1600-0447.1994.tb01515.x","article-title":"Benzodiazepines in the treatment of catatonic syndrome","volume":"89","author":"Ungvari","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.11.015_bb0800","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002130050904","article-title":"Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study","volume":"142","author":"Ungvari","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2022.11.015_bb0805","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2004.08.007","article-title":"Schizophrenia with prominent catatonic features ('catatonic schizophrenia'): I. Demographic and clinical correlates in the chronic phase","volume":"29","author":"Ungvari","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0810","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pnpbp.2008.10.010","article-title":"Schizophrenia with prominent catatonic features ('catatonic schizophrenia') III. Latent class analysis of the catatonic syndrome","volume":"33","author":"Ungvari","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0815","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/schbul\/sbp105","article-title":"The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders","volume":"36","author":"Ungvari","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2022.11.015_bb0820","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2017.08.008","article-title":"Schizophrenia with prominent catatonic features: a selective review","volume":"200","author":"Ungvari","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0825","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eurpsy.2005.03.012","article-title":"The use of atypical antipsychotics in the treatment of catatonia","volume":"20","author":"Van Den Eede","year":"2005","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0830","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00005053-199403000-00007","article-title":"Progression of symptoms in neuroleptic malignant syndrome","volume":"182","author":"Velamoor","year":"1994","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2022.11.015_bb0835","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000339456","article-title":"Motor symptoms and schizophrenia","volume":"66","author":"Walther","year":"2012","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2022.11.015_bb0840","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2020.07.003","article-title":"Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses - European consensus on assessment and perspectives","volume":"38","author":"Walther","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"19","key":"10.1016\/j.schres.2022.11.015_bb0845","first-page":"56","article-title":"Clinical analysis of low-dose amisulpride in the treatment of stupor in schizophrenia","volume":"19","author":"Wang","year":"2016","journal-title":"Chin. J. Pract. Nervous Dis."},{"issue":"16","key":"10.1016\/j.schres.2022.11.015_bb0850","first-page":"79","article-title":"Comparative study of modified ECT treatment for schizophrenia with stuporous state","volume":"18","author":"Wang","year":"2012","journal-title":"China Contemp. Med."},{"key":"10.1016\/j.schres.2022.11.015_bb0855","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2018.08.002","article-title":"ECT augmentation of clozapine for clozapine-resistant schizophrenia: a meta-analysis of randomized controlled trials","volume":"105","author":"Wang","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0860","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia","volume":"44","author":"Weinberger","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0865","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.biopsych.2022.08.001","article-title":"It's dopamine and schizophrenia all over again","volume":"92","author":"Weinberger","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0870","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00005053-197710000-00006","article-title":"Catatonia and malignant syndrome: a possible complication of neuroleptic administration","volume":"165","author":"Weinberger","year":"1977","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2022.11.015_bb0875","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0010-440X(73)90020-5","article-title":"Electroconvulsive treatment for schizophrenia. A ten-year survey in a university hospital psychiatric department","volume":"14","author":"Wells","year":"1973","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0880","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1192\/bjp.158.3.419","article-title":"Catatonia: harbinger of the neuroleptic malignant syndrome","volume":"158","author":"White","year":"1991","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0885","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1017\/S1092852900013419","article-title":"An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome","volume":"5","author":"White","year":"2000","journal-title":"CNS Spectr."},{"key":"10.1016\/j.schres.2022.11.015_bb0890","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.schres.2014.12.036","article-title":"The diagnostic criteria and structure of catatonia","volume":"164","author":"Wilson","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.11.015_bb0895","series-title":"International Classification of Diseases-10. Classification of Mental and Behavioural Disorders. Geneva","year":"1992"},{"key":"10.1016\/j.schres.2022.11.015_bb0900","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14025","article-title":"Prevalent gaps in understanding the features of catatonia among psychiatrists, psychiatry trainees, and medical students","volume":"82","author":"Wortzel","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.11.015_bb0905","doi-asserted-by":"crossref","first-page":"8739546","DOI":"10.1155\/2020\/8739546","article-title":"The presentation and treatment response of catatonia in patients admitted to the psychiatric inpatient unit at Jimma University Medical Center, Ethiopia","volume":"2020","author":"Yitayih","year":"2020","journal-title":"Psychiatry J."},{"key":"10.1016\/j.schres.2022.11.015_bb0910","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2147\/NDT.S52311","article-title":"Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients","volume":"9","author":"Yoshimura","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2022.11.015_bb0915","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/15622975.2011.564653","article-title":"Using ECT in schizophrenia: a review from a clinical perspective","volume":"13","author":"Zervas","year":"2012","journal-title":"World J. Biol. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422004315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422004315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:55:23Z","timestamp":1760298923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996422004315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":183,"alternative-id":["S0920996422004315"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.11.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of schizophrenia with catatonic symptoms: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}